Fingolimod Hydrochloride CAS 162359-56-0 Ịdị Ọcha ≥99.0% (HPLC) API Ụlọ Ọrụ Dị Ọcha Dị Elu

Nkọwa dị mkpirikpi:

Aha kemịkal: Fingolimod Hydrochloride

OZI: 162359-56-0

Ọdịdị: White ka Gbanyụọ-Ọcha ntụ ntụ

Dị ọcha: ≥99.0% (HPLC)

Ọgwụ FDA kwadoro maka ọgwụgwọ ọtụtụ Sclerosis.

API Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Onye nrụpụta nwere ịdị ọcha dị elu yana ogo kwụsiri ike
Aha kemịkal: Fingolimod Hydrochloride
OZI: 162359-56-0
Fingolimod Hydrochloride bụ ọgwụ FDA kwadoro maka ọgwụgwọ ọtụtụ Sclerosis.
API Ogo dị elu, mmepụta azụmahịa

Njirimara kemịkalụ:

Aha Chemical Fingolimod Hydrochloride
Ụdị okwu Fingolimod HCl;FTY 720
Nọmba CAS 162359-56-0
Nọmba CAT RF-API39
Ọnọdụ Ahịa Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms
Usoro ihe omimi C19H34ClNO2
Ibu molekụla 343.93
Ebe Na-agbaze 102.0 ~ 107.0°C
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Ọcha ka Gbanyụọ-Ọcha ntụ ntụ
njirimara HPLC
Ebe Na-agbaze 102.0 ~ 106.0 ℃
Solubility Na-agbaze kpamkpam n'ime mmiri
Ụzọ ịdị ọcha / nyocha ≥99.0% (HPLC)
Mmiri (KF) ≤0.50%
Ihe fọdụrụ na mgbanye ≤0.20%
Ọla dị arọ ≤20ppm
Ihe mgbaze fọdụrụnụ
Dichloromethane ≤0.05%
Ethyl acetate ≤0.50%
Ethanol ≤0.50%
Methanol ≤0.30%
Toluene ≤0.089%
THF ≤0.50%
DMF ≤0.088%
Ihe ndị ikwu
Otu adịghị ọcha ≤0.50%
Mgbakọta adịghị ọcha ≤1.0%
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ngwakọta ọgwụ na-arụ ọrụ (API)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.

Uru:

1

Ajụjụ:

Ngwa:

Shanghai Ruifu Chemical Co., Ltd. bụ onye na-emepụta ihe na onye na-ebubata Fingolimod Hydrochloride (CAS: 162359-56-0) nwere àgwà dị elu.
Fingolimod Hydrochloride bụ ọgwụ ọnụ nke mbụ maka ọgwụgwọ ọtụtụ sclerosis.Ụlọ ọrụ na-emepụta ọgwụ Novartis na-emepụta ya nke ọma, ma kwadoro ya maka ịzụ ahịa site na US Food and Drug Administration (FDA).Otutu sclerosis bụ ọrịa akwara na-akụda mmụọ nke nwere ike ime ka onye ọrịa ahụ kwụsị inwe mmetụta nke nguzozi, na-egosi spasms akwara na nsogbu mmegharị ahụ ndị ọzọ.Fingolimod Hydrochloride bụ sphingosine-l-phosphate (S1PR) modulator nnabata.Mgbe phosphorylation gasịrị, Ọ na-ejikọta ya na s1P onye na-anabata ya nke dị n'elu lymphocyte, nke ga-agbanwe mbịgharị lymphocyte, ma kwalite mkpụrụ ndụ n'ime anụ ahụ lymphatic, ma gbochie lymphocytes ịhapụ anụ ahụ lymphoid wee banye n'ime aka.N'ihi ya, ọ ga-egbochi mkpụrụ ndụ ndị a ịbanye n'ime usoro nhụjuanya nke etiti (CNS), nke na-enweta mmetụta nke immunosuppression.

Dee ozi gị ebe a ziga anyị ya